Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

Joey Kim, MD, Megha Patel-Banker, MD, Matthew Abramson, MD, Mehwish Bilal, MD, Sanjay Godhwani, MD, Asha Patnaik, MD, Heidi Roppelt, MD, & Qingping Yao, MD  |  Issue: November 2015  |  November 16, 2015

Figure 5A: A cerebral angiogram showing right MCA stenosis.

Figure 5A: A cerebral angiogram showing right MCA stenosis.

Compared with PACNS, CSF analysis is usually unremarkable in patients with moyamoya disease; however, unlike PACNS, diagnosis of moyamoya is typically made on the basis of radiological findings.7 To diagnose moyamoya disease, the following MRI–MRA criteria need to be met:5,6

  • Stenosis or occlusion of the terminal part of the ICA and/or the proximal portion of the ACA and/or MCA;
  • Visualization of an abnormal arterial vascular network around the stenotic and/or occluded lesions; and
  • Symmetry of the lesions, showing bilateral involvement.

Therefore, conventional digital subtraction angiography remains the gold standard for diagnosing moyamoya disease.7

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Because of moyamoya disease’s ability to mimic central nervous system vasculitis, it is important for rheumatologists to recognize this condition & diagnose it appropriately.

Treatment

Because PACNS is a very rare disease, no good randomized control trials comparing one treatment modality with another exist. The most commonly accepted treatment typically consists of glucocorticoids, possibly with cyclophosphomide.1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For moyamoya disease, no evidence suggests any benefit from corticosteroid therapy. Surgical revascularization for patients with ischemic moyamoya disease has been shown to decrease the frequency of transient ischemic attacks and risk of cerebral infarction.

Figure 5B: A cerebral angiogram showing left MCA stenosis.

Figure 5B: A cerebral angiogram showing left MCA stenosis.

On the other hand, for patients who cannot undergo surgical intervention, either due to recent infarction or good spontaneous revascularization, medical therapy with a cerebroprotective agent, edaravone, and an antithrombotic agent, such as aspirin, ozagrel, argatroban or heparin, is recommended. For hemorrhagic moyamoya disease, ventricular drainage and hematoma evacuation are the treatment modalities of choice.6

Conclusion

On initial presentation, both PACNS and moyamoya disease present similarly. Because treatment differs significantly, it’s important to differentiate between the two disorders. Given that both disorders can lead to permanent, serious, neurologic damage, it’s crucial that an accurate diagnosis be made so the correct treatment can be initiated as soon as possible.

Unlike PACNS, diagnosis of moyamoya is typically made on the basis of radiological findings.

Hopefully, by continuing to learn of these new cases, physicians will be better equipped to diagnose and treat these disorders appropriately and, thus, improve patient outcomes.


Dr. Kim

Dr. Kim

Joey Kim, MD, is an internal medicine resident currently finishing his third year of residency at Stony Brook University Hospital in New York. He hopes to pursue a career in rheumatology in the future.

Megha Patel-Banker, MD, is a board-certified rheumatologist who completed her fellowship training at Stony Brook University Hospital and currently practices in the Dallas area.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:case reportcentral nervous systemDiagnosismoyamoyapatient carerheumatologyTreatmentVasculitis

Related Articles

    Case Report: Lymphocytic Vasculitis of the Central Nervous System

    January 17, 2019

    Vasculitis is a group of chronic inflammatory diseases in which the blood vessel is the target of an immune reaction. They can be secondary to connective tissue disease, idiopathic or due to infection, neoplasm or drugs.1 Primary angiitis of the central nervous system (PACNS) is a rare syndrome characterized by inflammatory cell infiltration and necrosis…

    Meet the Lumbar Spinal Stenosis Challenge

    August 1, 2007

    Limited evidence and diagnostic options make this increasing condition difficult to treat

    7 Key Insights Into the Evaluation of Central Nervous System Vasculitis

    May 13, 2021

    Many a rheumatology consult has centered on a perplexing question: Does this patient have central nervous system (CNS) vasculitis? At the 2021 ACR State-of-the-Art Clinical Symposium, Rula Hajj-Ali, MD, FACP, professor of medicine and associate director of vasculitis care and research, Cleveland Clinic Lerner College of Medicine, discussed this topic in detail, providing a series…

    Meet the Challenge of Primary CNS Vasculitis

    September 1, 2011

    Diagnosis and treatment of this rare and poorly understood condition

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences